Asset Details
Do you wish to reserve the book?
Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development
Do you wish to request the book?
Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development
2013
Overview
Summary The rapid accumulation of knowledge on apoptosis regulation in the 1990s was followed by the development of several experimental anticancer‐ and anti‐ischaemia (stroke or myocardial infarction) drugs. Activation of apoptotic pathways or the removal of cellular apoptotic inhibitors has been suggested to aid cancer therapy and the inhibition of apoptosis was thought to limit ischaemia‐induced damage. However, initial clinical studies on apoptosis‐modulating drugs led to unexpected results in different clinical conditions and this may have been due to co‐effects on non‐apoptotic interconnected cell death mechanisms and the ‘yin‐yang’ role of autophagy in survival versus cell death. In this review, we extend the analysis of cell death beyond apoptosis. Upon introduction of molecular pathways governing autophagy and necrosis (also called necroptosis or programmed necrosis), we focus on the interconnected character of cell death signals and on the shared cell death processes involving mitochondria (e.g. mitophagy and mitoptosis) and molecular signals playing prominent roles in multiple pathways (e.g. Bcl2‐family members and p53). We also briefly highlight stress‐induced cell senescence that plays a role not only in organismal ageing but also offers the development of novel anticancer strategies. Finally, we briefly illustrate the interconnected character of cell death forms in clinical settings while discussing irradiation‐induced mitotic catastrophe. The signalling pathways are discussed in their relation to cancer biology and treatment approaches.
Publisher
John Wiley & Sons, Inc,Blackwell Publishing Ltd
Subject
/ Antineoplastic Agents - pharmacology
/ Cancer
/ DNA
/ Drugs
/ Erk
/ FOXO
/ Gene Expression Regulation, Neoplastic
/ Humans
/ Ischemia
/ Ligands
/ MEDICIN
/ MEDICINE
/ Necrosis
/ p53
/ PI3-K
/ Proto-Oncogene Proteins c-bcl-2 - genetics
/ Proto-Oncogene Proteins c-bcl-2 - metabolism
/ Receptors, Death Domain - genetics
/ Receptors, Death Domain - metabolism
/ Reviews
/ Rheb
/ S6K
